What is Structure Therapeutics Inc - ADR Annual Net Profit?

Structure Therapeutics Inc - ADR Annual Net Profit fell 36.72% in the last year to $122.53 M. Its sector's average net profit growth for the last fiscal year was -17.28%.

What is Structure Therapeutics Inc - ADR Price to Earning Ratio?

Structure Therapeutics Inc - ADR Price to Earning Ratio is -6.29, which is negative.

What is Structure Therapeutics Inc - ADR Stock Price?

Structure Therapeutics Inc - ADR Stock Price fell 69.74% and underperformed its sector by 68.37% in the past year.

What is Structure Therapeutics Inc - ADR Quarterly Net profit?

Structure Therapeutics Inc - ADR Quarterly Net profit fell 48.88% YoY to $36.48 M. Its sector's average net profit growth YoY for the quarter was -51.44%.

What is Structure Therapeutics Inc - ADR Debt to Equity Ratio?

Structure Therapeutics Inc - ADR Debt to Equity Ratio is zero as the company is debt-free.

What is Structure Therapeutics Inc - ADR Return on Equity(ROE)?

Structure Therapeutics Inc - ADR Return on Equity(ROE) for the last financial year was -18.6%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Structure Therapeutics Inc - ADR Mutual Fund Holding?

Structure Therapeutics Inc - ADR Mutual Fund Holding decreased by 1.67% in the last quarter to 65.6.

What is Structure Therapeutics Inc - ADR Institutional Holding?

Structure Therapeutics Inc - ADR Institutional Holding remained the same in the last quarter at 106.88%.

How is the Structure Therapeutics Inc - ADR today?

The Structure Therapeutics Inc - ADR today is trading in the down by -5.02% at 13.44.

How has Structure Therapeutics Inc - ADR performed historically?

The Structure Therapeutics Inc - ADR is currently trading down -5.02% on an intraday basis in the past week the index fell -16.00%. The index has been down -50.30% in the past quarter and fell -69.74% in the past year. You can view this in the overview section.

Structure Therapeutics Inc - ADR XNAS: GPCR

Structure Therapeutics Inc - ADR Live Share Price Today, Share Analysis and Chart

Name: Structure Therapeutics Inc - ADR: Is Infosys Ltd. worth buying?
Item: Structure Therapeutics Inc - ADR
Rating: 0.76700
Author: Trendlyne DVM scores

Download real time

13.44 -0.71 (-5.02%)

New 52W Low today

67,221 XNAS Volume

XNAS 09 Apr, 2025 9:41 AM (EDT)

Structure Therapeutics Inc... Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	770.7
PE TTM Negative PE TTM Unavailable in chosen country	-6.3
PEG TTM Below industry Median Unavailable in chosen country	0.2
Price to Book Below industry Median Unavailable in chosen country	0.9
Institutional holding current Qtr % High in industry Unavailable in chosen country	106.9
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-48.9
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-36.7
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-41.3
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-18.6
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-17.7

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

11.5 / 100

Technically Bearish

19.2 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Structure Therapeutics Inc... Stock Price Analysis

Day Price Range -5.0% 1 Day return Unavailable in chosen country	13.4 (LTP) 13.213.7 LowHigh
Week Price Range -16.0% 1 Week return Unavailable in chosen country	13.4 (LTP) 13.217.3 LowHigh
Month Price Range -40.6% 1 Month return Unavailable in chosen country	13.4 (LTP) 13.223.5 LowHigh
52 Week Price Range -69.7% 1 Year return Unavailable in chosen country	13.4 (LTP) 13.262.7 LowHigh

View full Share Price History

Structure Therapeutics Inc... Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Structure Therapeutics Inc... Stock Analysis

Structure Therapeutics Inc... stock analysis with key metrics, changes, and trends.

Structure Therapeutics Inc... Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$122.53 M	36.72%	negative	Annual Net Profit fell 36.72% in the last year to $122.53 M. Its sector's average net profit growth for the last fiscal year was -17.28%.
Price to Earning Ratio	-6.29	-	negative	Price to Earning Ratio is -6.29, which is negative.
Stock Price	$13.44	-69.74%	negative	Stock Price fell 69.74% and underperformed its sector by 68.37% in the past year.
Quarterly Net profit	$36.48 M	48.88%	negative	Quarterly Net profit fell 48.88% YoY to $36.48 M. Its sector's average net profit growth YoY for the quarter was -51.44%.
Debt to Equity Ratio	-	-	positive	Debt to Equity Ratio is zero as the company is debt-free.
Return on Equity(ROE)	-18.60 %	-18.6%	negative	Return on Equity(ROE) for the last financial year was -18.6%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	65.60 %	-1.67%	negative	Mutual Fund Holding decreased by 1.67% in the last quarter to 65.6.
Institutional Holding	106.88 %	0%	neutral	Institutional Holding remained the same in the last quarter at 106.88%.

VIEW LESS

Loading data..

Structure Therapeutics Inc - ADR - Company Profile

What does Structure Therapeutics Inc - ADR do?

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Gross Remuneration

2024

Gross Remuneration

Year

Structure Therapeutics Inc - ADR Live Share Price Today, Share Analysis and Chart

New 52W Low today

Structure Therapeutics Inc... Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Structure Therapeutics Inc... Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Structure Therapeutics Inc... Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Structure Therapeutics Inc... Stock Analysis

Structure Therapeutics Inc... stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 36.72% in the last year to $122.53 M. Its sector's average net profit growth for the last fiscal year was -17.28%.

Price to Earning Ratio is -6.29, which is negative.

Stock Price fell 69.74% and underperformed its sector by 68.37% in the past year.

Quarterly Net profit fell 48.88% YoY to $36.48 M. Its sector's average net profit growth YoY for the quarter was -51.44%.

Debt to Equity Ratio is zero as the company is debt-free.

Return on Equity(ROE) for the last financial year was -18.6%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.67% in the last quarter to 65.6.

Institutional Holding remained the same in the last quarter at 106.88%.

Structure Therapeutics Inc - ADR - Company Profile

What does Structure Therapeutics Inc - ADR do?

Structure Therapeutics Inc - ADR Management structure

Ms. Ashley F. Hall, J.D.

Chief Development Officer

Dr. Mark Bach, M.D.,PhD

Chief Medical Officer

Dr. Blai Coll

Chief Medical Officer

Professor Raymond C. Stevens, PhD

Director and Chief Executive Officer

Mr. Jun Yoon

Director, Principal Accounting Officer and Chief Financial Officer

Structure Therapeutics Inc - ADR Board of directors

Dr. Ramy Farid, PhD

Independent Director

Mr. Angus Charles Russell

Independent Director

Mr. Eric L. Dobmeier, J.D.

Independent Director

Ms. Sharon E. Tetlow

Independent Director

Dr. Ted W. Love, M.D.

Independent Director

Mr. Daniel G. Welch

Chairman of the Board

Structure Therapeutics Inc - ADR FAQ

How is Structure Therapeutics Inc - ADR today?

Structure Therapeutics Inc - ADR today is trading in the red, and is down by -5.02% at 13.44.

How has Structure Therapeutics Inc - ADR performed historically?

Structure Therapeutics Inc - ADR is currently trading down -5.02% on an intraday basis. In the past week the stock fell -16.00%. stock has been down -50.30% in the past quarter and fell -69.74% in the past year. You can view this in the overview section.